Tariffs On Pharma: A Double-Edged Sword For The US?

Tariffs On Pharma: A Double-Edged Sword For The US?



From Washington’s vantage point, a full-fledged tariff on patented and branded products is meant to boost domestic manufacturing in the country, but there are caveats.



Source link